BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 14612666)

  • 1. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
    Imai K; Nonoyama S; Ochs HD
    Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiskott-Aldrich Syndrome: a model for defective actin reorganization, cell trafficking and synapse formation.
    Notarangelo LD; Ochs HD
    Curr Opin Immunol; 2003 Oct; 15(5):585-91. PubMed ID: 14499269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of the Wiskott-Aldrich syndrome protein.
    Ochs HD; Notarangelo LD
    Curr Opin Hematol; 2005 Jul; 12(4):284-91. PubMed ID: 15928485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wiskott-Aldrich syndrome/X-linked thrombocytopenia in China: Clinical characteristic and genotype-phenotype correlation.
    Liu DW; Zhang ZY; Zhao Q; Jiang LP; Liu W; Tu WW; Song WX; Zhao XD
    Pediatr Blood Cancer; 2015 Sep; 62(9):1601-8. PubMed ID: 25931402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
    Snapper SB; Rosen FS
    Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASp) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASp effector function and T cell activation.
    Badour K; Zhang J; Shi F; Leng Y; Collins M; Siminovitch KA
    J Exp Med; 2004 Jan; 199(1):99-112. PubMed ID: 14707117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding.
    Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS
    J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation.
    Jin Y; Mazza C; Christie JR; Giliani S; Fiorini M; Mella P; Gandellini F; Stewart DM; Zhu Q; Nelson DL; Notarangelo LD; Ochs HD
    Blood; 2004 Dec; 104(13):4010-9. PubMed ID: 15284122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wiskott-Aldrich syndrome protein and platelets.
    Oda A; Ochs HD
    Immunol Rev; 2000 Dec; 178():111-7. PubMed ID: 11213795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology of the Wiskott-Aldrich syndrome.
    Rengan R; Ochs HD
    Rev Immunogenet; 2000; 2(2):243-55. PubMed ID: 11258421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.
    Ochs HD
    Immunol Res; 2009; 44(1-3):84-8. PubMed ID: 19082760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective actin polymerization in EBV-transformed B-cell lines from patients with the Wiskott-Aldrich syndrome.
    Facchetti F; Blanzuoli L; Vermi W; Notarangelo LD; Giliani S; Fiorini M; Fasth A; Stewart DM; Nelson DL
    J Pathol; 1998 May; 185(1):99-107. PubMed ID: 9713366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wiskott-Aldrich syndrome.
    Notarangelo LD; Miao CH; Ochs HD
    Curr Opin Hematol; 2008 Jan; 15(1):30-6. PubMed ID: 18043243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel mutations in the Wiskott-Aldrich syndrome protein gene and their effects on transcriptional, translational, and clinical phenotypes.
    Lemahieu V; Gastier JM; Francke U
    Hum Mutat; 1999; 14(1):54-66. PubMed ID: 10447259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the WASP gene in 10 Japanese patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
    Itoh S; Nonoyama S; Morio T; Imai K; Okawa H; Ochs HD; Shimadzu M; Yata J
    Int J Hematol; 2000 Jan; 71(1):79-83. PubMed ID: 10729999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Wiskott-Aldrich syndrome.
    Orange JS; Stone KD; Turvey SE; Krzewski K
    Cell Mol Life Sci; 2004 Sep; 61(18):2361-85. PubMed ID: 15378206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Molecular pathogenesis of Wiskott-Aldrich syndrome].
    Sasahara Y; Tsuchiya S
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):140-7. PubMed ID: 15997177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wiskott-Aldrich syndrome iPS cells produce megakaryocytes with defects in cytoskeletal rearrangement and proplatelet formation.
    Ingrungruanglert P; Amarinthnukrowh P; Rungsiwiwut R; Maneesri-le Grand S; Sosothikul D; Suphapeetiporn K; Israsena N; Shotelersuk V
    Thromb Haemost; 2015 Apr; 113(4):792-805. PubMed ID: 25518736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
    Blundell MP; Worth A; Bouma G; Thrasher AJ
    Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Identification of two novel WASP gene mutations in 3 boys with Wiskott-Aldrich syndrome].
    Jiang LP; Xu YH; Yang XQ; Liu EM; Wang LJ; Lau YL; Chan KW
    Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):590-3. PubMed ID: 14744380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.